We don't know whether the most recent response to this request contains information or not – if you are Z. Dare please sign in and let everyone know.

Details of second dose incidents of VITT following AZ vaccine

We're waiting for Z. Dare to read a recent response and update the status.

Dear Medicines and Healthcare products Regulatory Agency,

Please share details of the so far reported six incidents of VITT following second dose of Astra Zeneca's Covid-19 vaccine, including:

- Degree to which symptoms matched typical VITT cases following first dose
- Age of patients (or decade of age if required for patient confidentiality)
- Time of onset following second vaccination
- Any pre-existing auto-immune conditions or blood clotting disorders suffered by the patients
- Fatality rate

Yours faithfully,
Z. Dare

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
We will respond to you as soon as possible. 

 

Please note that we may not respond if your query: 

 

• contains offensive language
• has already been answered in a previous reply to you
• is illegible
• is selling or promoting a product
• is for information only 

 

Medicines and Healthcare products Regulatory Agency
10 South Colonnade, 
Canary Wharf, 
London 
E14 4PU
gov.uk/mhra
Stay connected 
 
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC. 

 

The UK has left the EU, and the transition period ends on 31 December
2020. Our [1]guidance and information can be accessed here. 

References

Visible links
1. https://www.gov.uk/government/collection...

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

 

 

Our Ref: FOI 21/496

       

Dear Z. Dare,

       

RE:  REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000

        

Thank you for your enquiry which we received on 8^th May 2021.

  

I confirm that your request is now being handled under the Freedom of
Information Act and you should receive a reply within 20 working days from
our date of receipt. 

 

If you need to contact us again about this request, please quote the
reference number above.

 

Please be aware that we publish FOIs replies and these are redacted and
are located on our website at the following link below.

[1]https://www.gov.uk/government/collection...

        

Kind Regards,

 

 

MHRA Customer Service Centre

 

Medicines and Healthcare products Regulatory Agency

10 South Colonnade, Canary Wharf, London E14 4PU

Telephone 0203 080 6000

 

 

 

show quoted sections

Pharmacovigilanceservice, Medicines and Healthcare Products Regulatory Agency

1 Attachment

Dear Z Dare,

Please find attached the response to your FOI request.

Kind regards,

 

FOI Team

Vigilance and Risk Management of Medicines Division

Medicines and Healthcare Products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU

 

 

 

 

show quoted sections

We don't know whether the most recent response to this request contains information or not – if you are Z. Dare please sign in and let everyone know.